Jane Street Group, LLC Iterum Therapeutics PLC Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.19 - $0.36 $7,074 - $13,404	37,235 New	37,235 $7,000
Q1 2022 May 17, 2022	SELL	$0.31 - $0.45 $41,091 - $59,648	-132,552 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.39 - $0.74 $46,710 - $88,629	119,770 Added 937.02%	132,552 $52,000
Q3 2021 Nov 16, 2021	BUY	$0.54 - $2.29 $6,902 - $29,270	12,782 New	12,782 $7,000
Q2 2021 Aug 16, 2021	SELL	$0.97 - $2.39 $17,499 - $43,117	-18,041 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$0.97 - $2.73 $17,499 - $49,251	18,041 New	18,041 $25,000

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $15.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.